Dimed S.A. Distribuidora de Medicamentos (PNVL3) Stock Statistics & Valuation Metrics

Dimed S.A. Distribuidora de Medicamentos has a market cap or net worth of $1.50B. The enterprise value is $2.78B.

Market Cap

$1.50B

Enterprise Value

$2.78B

Dimed S.A. Distribuidora de Medicamentos has 150,377,490 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

150,377,490

Owned by Insiders

―

Owned by Institutions

―

Dimed S.A. Distribuidora de Medicamentos’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.19%.

Return on Equity (ROE)

0.10

Return on Assets (ROA)

0.03

Return on Invested Capital (ROIC)

7.19%

Return on Capital Employed (ROCE)

0.09

Revenue Per Employee

482.42K

Profits Per Employee

10.91K

Employee Count

11,426

Asset Turnover

1.44

Inventory Turnover

3.39

The current PE Ratio of Dimed S.A. Distribuidora de Medicamentos is 10.96. Dimed S.A. Distribuidora de Medicamentos’s PEG ratio is 0.67.

PE Ratio

10.96

PS Ratio

0.26

PB Ratio

1.14

Price to FCF

6.18

Price to Operating Cash Flow

4.16

PEG Ratio

0.67

In the last 12 months, Dimed S.A. Distribuidora de Medicamentos had revenue of 5.51B and earned 124.61M in profits. Earnings per share was 0.84.

Revenue

5.51B

Gross Profit

1.55B

Operating Income

238.29M

Pretax Income

145.54M

Net Income

124.61M

EBITDA

470.83M

Earnings Per Share (EPS)

0.84

In the last 12 months, operating cash flow was 362.11M and capital expenditures -118.39M, giving a free cash flow of 243.72M billion.

Operating Cash Flow

362.11M

Free Cash Flow

243.72M

Free Cash Flow per Share

1.63

Dimed S.A. Distribuidora de Medicamentos pays an annual dividend of ―, resulting in a dividend yield of 4.73%

Dividend Per Share

―

Dividend Yield

4.73%

Payout Ratio

N/A

Free Cash Flow Yield

16.19%

Earnings Yield

9.14%

Beta

1.49

52-Week Price Change

7.69%

50-Day Moving Average

13.24

200-Day Moving Average

12.87

Relative Strength Index (RSI)

27.23

Average Volume (3m)

1.05M

Dimed S.A. Distribuidora de Medicamentos upcoming earnings date is Nov 05, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 06, 2026

Next Earnings Date

Nov 05, 2026

Ex-Dividend Date

―

Dimed S.A. Distribuidora de Medicamentos as a current ratio of 1.74, with Debt / Equity ratio of 117.51%

Current Ratio

1.74

Quick Ratio

0.86

Debt to Market Cap

0.40

Net Debt to EBITDA

3.11

Interest Coverage Ratio

1.72

In the past 12 months, Dimed S.A. Distribuidora de Medicamentos has paid 20.93M in taxes.

Income Tax

20.93M

Effective Tax Rate

0.14

Dimed S.A. Distribuidora de Medicamentos EV to EBITDA ratio is 5.46, with an EV/FCF ratio of 11.69.

EV to Sales

0.48

EV to EBITDA

5.46

EV to Free Cash Flow

11.69

EV to Operating Cash Flow

7.87

Dimed S.A. Distribuidora de Medicamentos has $295.20M in cash and marketable securities with $1.40B in debt, giving a net cash position of -$1.11B billion.

Cash & Marketable Securities

$295.20M

Total Debt

$1.40B

Net Cash

-$1.11B

Net Cash Per Share

-$7.37

Tangible Book Value Per Share

$8.09

Gross margin is 28.23%, with operating margin of 4.56%, and net profit margin of 2.33%.

Gross Margin

28.23%

Operating Margin

4.56%

Pretax Margin

2.73%

Net Profit Margin

2.33%

EBITDA Margin

8.84%

EBIT Margin

4.74%

The average price target for Dimed S.A. Distribuidora de Medicamentos is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

14.42%

EPS Growth Forecast

17.29%